Jens Samol

2.0k total citations
33 papers, 537 citations indexed

About

Jens Samol is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jens Samol has authored 33 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Jens Samol's work include Lung Cancer Treatments and Mutations (8 papers), Viral-associated cancers and disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jens Samol is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Viral-associated cancers and disorders (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Jens Samol collaborates with scholars based in Singapore, United States and United Kingdom. Jens Samol's co-authors include Hermann Herbst, Gerald Niedobitek, Edwina N. Scott, Euan Macpherson, Malcolm Ranson, James T. Cassidy, James Carmichael, Anne Thomas, Angelo Agathanggelou and H. Klotzbach and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jens Samol

23 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jens Samol Singapore 9 334 219 164 111 59 33 537
Francesca Lunghi Italy 8 164 0.5× 85 0.4× 148 0.9× 66 0.6× 31 0.5× 19 378
Anjum Hassan United States 16 168 0.5× 220 1.0× 88 0.5× 100 0.9× 25 0.4× 39 540
Ornella Carminati Italy 8 329 1.0× 48 0.2× 149 0.9× 56 0.5× 65 1.1× 13 445
Barbara Jezeršek Novaković Slovenia 12 164 0.5× 184 0.8× 98 0.6× 45 0.4× 47 0.8× 43 400
Vivian Weiß United States 17 305 0.9× 62 0.3× 155 0.9× 188 1.7× 54 0.9× 55 714
S. N. Markovic United States 8 352 1.1× 184 0.8× 203 1.2× 123 1.1× 11 0.2× 25 618
Christina Nickenig Germany 11 272 0.8× 378 1.7× 73 0.4× 63 0.6× 26 0.4× 20 569
Gérard Buchonnet France 15 229 0.7× 336 1.5× 128 0.8× 70 0.6× 23 0.4× 27 566
Brian Elliott United States 11 359 1.1× 261 1.2× 88 0.5× 59 0.5× 27 0.5× 32 482
T. P. Vassilakopoulos Greece 12 160 0.5× 271 1.2× 81 0.5× 108 1.0× 17 0.3× 19 502

Countries citing papers authored by Jens Samol

Since Specialization
Citations

This map shows the geographic impact of Jens Samol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Samol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Samol more than expected).

Fields of papers citing papers by Jens Samol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Samol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Samol. The network helps show where Jens Samol may publish in the future.

Co-authorship network of co-authors of Jens Samol

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Samol. A scholar is included among the top collaborators of Jens Samol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Samol. Jens Samol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Kakoli, et al.. (2026). Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology. Cancers. 18(2). 327–327.
2.
Samol, Jens, Jonathan Poh, Min-Han Tan, et al.. (2025). Prospective Multicenter Study Evaluating a Combined Circulating Tumor DNA and Circulating Tumor RNA Liquid Biopsy in Metastatic Non–Small Cell Lung Cancer (LIQUIK). JCO Precision Oncology. 9(9). e2500181–e2500181. 4 indexed citations
3.
Hong, Jung Yong, Maxime Chénard-Poirier, B-Y. Ryoo, et al.. (2025). 9O Phase I/II, open-label, first-in-human study of the anti-GPC3 T cell engager SAR444200 in patients with advanced solid tumors: Updated safety and pharmacokinetic analysis. ESMO Open. 10. 104165–104165. 1 indexed citations
4.
5.
Lui, Rashid N., et al.. (2024). Beyond a vestigial organ: effects of the appendix on gut microbiome and colorectal cancer. Journal of Gastroenterology and Hepatology. 39(5). 826–835. 4 indexed citations
6.
7.
Lai, Gillianne, Xin Cheng, Yvonne Ang, et al.. (2023). Molecular testing in non-small cell lung cancer: A consensus recommendation. Annals of the Academy of Medicine Singapore. 52(7). 364–373.
8.
Jiang, Hong, B-Y. Ryoo, Maxime Chénard-Poirier, et al.. (2023). 1046P Phase I/II open-label study on an anti-GPC3 T cell engager, SAR444200, in patients with advanced solid tumors: Preliminary dose escalation results. Annals of Oncology. 34. S634–S634. 5 indexed citations
9.
Le, Xiuning, Anna Eisert, Te‐Chun Hsia, et al.. (2023). Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series.. Journal of Clinical Oncology. 41(16_suppl). 9070–9070.
10.
11.
12.
Ang, Yvonne, Puey Ling Chia, Kevin Lee Min Chua, et al.. (2021). Lung Cancer in Singapore. Journal of Thoracic Oncology. 16(6). 906–911. 3 indexed citations
13.
Ezzat, Vivienne, et al.. (2014). Lynch Syndrome and Long QT Syndrome – As If One Syndrome is Not Already Enough. European Oncology & Haematology. 10(1). 25–25.
14.
Samol, Jens, et al.. (2012). Overestimation of carboplatin doses is avoided by radionuclide GFR measurement. British Journal of Cancer. 107(8). 1310–1316. 28 indexed citations
15.
Samol, Jens, Malcolm Ranson, Edwina N. Scott, et al.. (2011). Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study. Investigational New Drugs. 30(4). 1493–1500. 124 indexed citations
16.
Samol, Jens, et al.. (2009). Unexpected finding on staging bone marrow aspirate for Hodgkin’s lymphoma. BMJ Case Reports. 2009. bcr1220081298–bcr1220081298.
17.
18.
19.
Herbst, Hermann, et al.. (1997). Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. The Journal of Pathology. 182(3). 299–306. 38 indexed citations
20.
Foss, Hans‐Dieter, Hermann Herbst, Elisabeth Oelmann, et al.. (1993). Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease cases. British Journal of Haematology. 84(4). 627–635. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Lunghi Breakdown of academic impact, for papers by Anjum Hassan Breakdown of academic impact, for papers by Ornella Carminati Breakdown of academic impact, for papers by Barbara Jezeršek Novaković Breakdown of academic impact, for papers by Vivian Weiß Breakdown of academic impact, for papers by S. N. Markovic Breakdown of academic impact, for papers by Christina Nickenig Breakdown of academic impact, for papers by Gérard Buchonnet Breakdown of academic impact, for papers by Brian Elliott Breakdown of academic impact, for papers by T. P. Vassilakopoulos
Rankless by CCL
2026